Osaic Holdings’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$60.5K Sell
38,290
-393
-1% -$663 ﹤0.01% 5059
2025
Q4
$64.6K Sell
38,683
-46,113
-54% -$79.8K ﹤0.01% 5058
2025
Q3
$123K Buy
84,796
+3,319
+4% +$3.93K ﹤0.01% 4613
2025
Q2
$73.6K Sell
81,477
-15,775
-16% -$9.36K ﹤0.01% 4754
2025
Q1
$43.8K Buy
97,252
+40,516
+71% +$23.8K ﹤0.01% 4821
2024
Q4
$28.4K Sell
56,736
-7,315
-11% -$5.37K ﹤0.01% 5106
2024
Q3
$58.1K Buy
64,051
+16,912
+36% +$15.7K ﹤0.01% 4639
2024
Q2
$47K Buy
47,139
+45,052
+2,159% +$49.8K ﹤0.01% 4725
2024
Q1
$3.09K Sell
2,087
-106
-5% -$120 ﹤0.01% 6304
2023
Q4
$2.39K Sell
2,193
-44,178
-95% -$48.4K ﹤0.01% 6476
2023
Q3
$54.7K Sell
46,371
-394
-0.8% -$536 ﹤0.01% 4942
2023
Q2
$65.9K Buy
46,765
+81
+0.2% +$112 ﹤0.01% 4752
2023
Q1
$70K Hold
46,684
﹤0.01% 4728
2022
Q4
$54.9K Buy
46,684
+44,400
+1,944% +$56K ﹤0.01% 4863
2022
Q3
$2K Hold
2,284
﹤0.01% 6786
2022
Q2
$3K Hold
2,284
﹤0.01% 6731
2022
Q1
$3K Hold
2,284
﹤0.01% 6739
2021
Q4
$5K Sell
2,284
-89
-4% -$208 ﹤0.01% 6634
2021
Q3
$6K Sell
2,373
-400
-14% -$1.03K ﹤0.01% 6446
2021
Q2
$13K Sell
2,773
-3,123
-53% -$8.08K ﹤0.01% 5909
2021
Q1
$13K Buy
5,896
+3,580
+155% +$8.6K ﹤0.01% 5737
2020
Q4
$4K Sell
2,316
-698
-23% -$976 ﹤0.01% 5856
2020
Q3
$3K Buy
3,014
+19
+0.6% +$17 ﹤0.01% 5733
2020
Q2
$2K Buy
2,995
+134
+5% +$118 ﹤0.01% 5799
2020
Q1
$2K Buy
+2,861
New +$2.85K ﹤0.01% 5692

Other funds holding LCTX